During the past decade, Klin. Abt. für Onkologie, AKH Wien conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klin. Abt. für Onkologie, AKH Wien" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Klin. Abt. für Onkologie, AKH Wien" in a lesser frequency.

Most popular intervention types in "Klin. Abt. für Onkologie, AKH Wien" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "allogeneic stem cell transplant" (1 trials) and "bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klin. Abt. für Onkologie, AKH Wien" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klin. Abt. für Onkologie, AKH Wien". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Klin. Abt. für Onkologie, AKH Wien, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klin. Abt. für Onkologie, AKH Wien, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".